Tissue Regeneration Products for Sports Medicine Injuries
Regen Biologics has developed and marketed innovative and tissue regeneration products for sports medicine injuries worldwide.
Regen was founded in 1990 and has its headquarters in New Jersey, USA. Hospital Innovations, in collaboration with Regen, is delighted to launch the Menaflex Meniscal Implant into the UK market for the treatment of damaged menisci. Based on controlled studies, Menaflex has been proven safe and effective by the lack of clinically significant complications. Please see more information on the Regen Link or contact our Customer Services for more information
